Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Pharyngeal Neoplasms × Erlotinib Hydrochloride × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 2 Tonsillar Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pharyngeal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Oncolytic Virotherapy 1 Erlotinib Hydrochloride 1 Cisplatin 1 Chemoradiotherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00140556 2013-01-18

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Duke University

Phase EARLY_PHASE1 Completed

28 enrolled 8 charts

Head and Neck Neoplasms, Pharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡